1 |
E. Furst Daniel, Meloxicam: Selective COX-2 Inhibition in Clinical Practice, Semin. Arthritis. Rheum., 26, 6, SUPPL 1, 21-27 (1997)
DOI
ScienceOn
|
2 |
G. C. Mazzenga, B. Berner, The transdermal delivery of zwitterionic drugs I: the solubility of zwitterion salts, J. Control. Release, 16, 77-88 (1991)
DOI
ScienceOn
|
3 |
B. Thomas, and B. Finnin, The transdermal revolution, Drug Discov. Today, 16, 697-703 (2004)
|
4 |
M. Buffum and J. C. Buffum, Nonsteroidal anti-inflammtory drugs in the elderly, Pain. Manag. Nurs., 1, 2, 40-50 (2000)
DOI
ScienceOn
|
5 |
C. S. Asbill and B. B. Michniak, Percutaneous penetration enhancers: local versus transdermal activity, Pharmaceut. Sci. Tech. Today, 3, 1, 36-41 (2000)
DOI
ScienceOn
|
6 |
S. C. McNeill, R. O. Potts and M. L. Francoeur, Local enhanced topical delivery (LETD) of drugs: does it truly exist?, Pharm. Res., 9, 1442-1427 (1992)
DOI
|
7 |
D. Turck, U. Busch, G. Heinzel and H. Narjes, Clinical pharmacokinetics of meloxicam, Arzneimittelforsch, 47, 3, 253-258 (1997)
|
8 |
Y. J. Cho and H. K. Choi, Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix, Int. J. Pharm., 169, 95-104 (1998)
DOI
ScienceOn
|
9 |
H. M. Ki and H. K. Choi, The effect of meloxicam/ethanolamine salt formation on percutaneus absorption of meloxicam, Arch. Pharm. Res., 30, 2, 215-221 (2007)
과학기술학회마을
DOI
ScienceOn
|
10 |
H. A. Cheong, H. K. Choi, Effect of ethanolamine salts and enhancers on the percutaneous absorption of piroxicam from a pressure sensitive adhesive matrix, Eur. J. Pharm. Sci., 18, 149-153 (2003)
DOI
ScienceOn
|
11 |
T. Kokubo, K. Sugibayashi and Y. Morimoto, Interaction between drugs and pressure-sensitive adhesives in transdermal therapeutic systems, Pharm. Res., 11, 104-107 (1994)
DOI
|
12 |
A. Femenial-Font, C. Balaguer-Fernandez, Merno V., Rodilla V., Lopez-Casellano A., Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate, Eur. J. Pharm. Biopharm., 61, 50-55 (2005)
DOI
ScienceOn
|